Biocon

Biocon is a biopharmaceutical company based in India, known for its innovative work in developing and manufacturing drugs, especially in areas like diabetes, cancer, and autoimmune diseases. Founded in 1978 by Kiran Mazumdar-Shaw, it has grown to become a major player in biotechnology, focusing on both biosimilars—medicines that are similar to already approved biological products—and novel biologics. Biocon's efforts aim to make healthcare more accessible and affordable, enhancing treatment options for patients worldwide. The company also invests in research and development to advance medical science and improve health outcomes.